Assenagon Asset Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.3M | Hold |
919,079
| – | – | 0.01% | 540 |
|
|
2025
Q1 | $6.07M | Buy |
919,079
+13,895
| +2% | +$91.7K | 0.01% | 492 |
|
|
2024
Q4 | $7.88M | Sell |
905,184
-146,879
| -14% | -$1.28M | 0.01% | 545 |
|
|
2024
Q3 | $20.6M | Sell |
1,052,063
-679,514
| -39% | -$13.3M | 0.04% | 314 |
|
|
2024
Q2 | $35.7M | Buy |
1,731,577
+577,732
| +50% | +$11.9M | 0.08% | 173 |
|
|
2024
Q1 | $24.6M | Hold |
1,153,845
| – | – | 0.06% | 224 |
|
|
2023
Q4 | $16.6M | Hold |
1,153,845
| – | – | 0.04% | 307 |
|
|
2023
Q3 | $10.5M | Hold |
1,153,845
| – | – | 0.03% | 348 |
|
|
2023
Q2 | $12.2M | Hold |
1,153,845
| – | – | 0.04% | 300 |
|
|
2023
Q1 | $14.1M | Hold |
1,153,845
| – | – | 0.05% | 294 |
|
|
2022
Q4 | $14.3M | Sell |
1,153,845
-2,642
| -0.2% | -$32.8K | 0.05% | 286 |
|
|
2022
Q3 | $15.8M | Hold |
1,156,487
| – | – | 0.06% | 250 |
|
|
2022
Q2 | $21.2M | Sell |
1,156,487
-523,709
| -31% | -$9.6M | 0.08% | 200 |
|
|
2022
Q1 | $27M | Buy |
1,680,196
+1,158,356
| +222% | +$18.6M | 0.08% | 187 |
|
|
2021
Q4 | $7.31M | Sell |
521,840
-316,493
| -38% | -$4.43M | 0.02% | 384 |
|
|
2021
Q3 | $15.7M | Buy |
838,333
+304,254
| +57% | +$5.7M | 0.05% | 200 |
|
|
2021
Q2 | $11.1M | Buy |
534,079
+415,879
| +352% | +$8.67M | 0.04% | 295 |
|
|
2021
Q1 | $3.34M | Hold |
118,200
| – | – | 0.01% | 565 |
|
|
2020
Q4 | $3.86M | Sell |
118,200
-205,200
| -63% | -$6.7M | 0.02% | 373 |
|
|
2020
Q3 | $9.91M | Buy |
+323,400
| New | +$9.91M | 0.06% | 167 |
|
|
2018
Q3 | – | Sell |
-20,602
| Closed | -$375K | – | 768 |
|
|
2018
Q2 | $375K | Sell |
20,602
-24,693
| -55% | -$449K | ﹤0.01% | 379 |
|
|
2018
Q1 | $849K | Buy |
+45,295
| New | +$849K | 0.01% | 380 |
|